VOCs Biosensing Kit
South Korea's CD BIO Seeks Clinical Trial, FDA Registration for Its VOCs Biosensing Kit That Detects Early Stage Lung and Other Cancers With Simple Breathing Test
05 sept. 2022 09h01 HE | CD BIO
LOS ANGELES, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Korean technicians announced on the 30th that they have developed a diagnostic device that diagnoses lung cancer from breathing tests. They have plans...